Literature DB >> 10233417

Concurrent chromosomal alterations at 3q27, 8q24 and 18q21 in B-cell lymphomas.

W Y Au1, R D Gascoyne, D S Viswanatha, B F Skinnider, J M Connors, R J Klasa, D E Horsman.   

Abstract

Recurrent chromosomal translocations in malignant lymphomas most commonly involve 18q21(bcl-2), 8q24 (c-myc) and 3q27 (bcl-6), with an incidence of 27%, 11% and 6%, respectively. Individual cases concurrently harbouring two of these three rearrangements have been previously reported. This report describes four patients with cytogenetic alterations affecting all three loci, which was confirmed by molecular analysis in one case. Clinically, each patient had aggressive B-cell lymphoma with disseminated disease often involving the central nervous system, poor response to chemotherapy and short survival. Activation of c-myc in association with deregulation of bcl-2, bcl-6 or both confers high-grade disease with a poor prognosis.

Entities:  

Mesh:

Year:  1999        PMID: 10233417

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  7 in total

Review 1.  A Novel Non-Immunoglobulin (non-Ig)/BCL6 Translocation in Diffuse Large B-Cell Lymphoma Involving Chromosome 10q11.21 Loci and Review on Clinical Consequences of BCL6 Rearrangements.

Authors:  Marie Jarosova; Eva Kriegova; Petra Schneiderova; Regina Fillerova; Vit Prochazka; Michaela Mikesova; Patrik Flodr; Karel Indrak; Tomas Papajik
Journal:  Pathol Oncol Res       Date:  2015-08-30       Impact factor: 3.201

2.  Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival.

Authors:  Nathalie A Johnson; Kerry J Savage; Olga Ludkovski; Susana Ben-Neriah; Ryan Woods; Christian Steidl; Martin J S Dyer; Reiner Siebert; John Kuruvilla; Richard Klasa; Joseph M Connors; Randy D Gascoyne; Douglas E Horsman
Journal:  Blood       Date:  2009-07-13       Impact factor: 22.113

3.  Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations.

Authors:  Naoto Tomita; Mami Tokunaka; Naoya Nakamura; Kengo Takeuchi; Junki Koike; Shigeki Motomura; Ko Miyamoto; Ako Kikuchi; Rie Hyo; Yoshihiro Yakushijin; Yasufumi Masaki; Soichiro Fujii; Takamasa Hayashi; Yoshiaki Ishigatsubo; Ikuo Miura
Journal:  Haematologica       Date:  2009-06-16       Impact factor: 9.941

4.  A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial).

Authors:  Graham M Mead; Sharon L Barrans; Wendi Qian; Jan Walewski; John A Radford; Max Wolf; Simon M Clawson; Sally P Stenning; Claire L Yule; Andrew S Jack
Journal:  Blood       Date:  2008-07-08       Impact factor: 22.113

Review 5.  Double-hit and triple-hit lymphomas arising from follicular lymphoma following acquisition of MYC: report of two cases and literature review.

Authors:  Xiaoxiao Xu; Le Zhang; Yafei Wang; Qing Zhang; Lianyu Zhang; Baocun Sun; Yizhuo Zhang
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15

6.  Maintenance and characterization of an Epstein Barr virus-infected CD56-negative T cell lymphoma.

Authors:  Izuru Maekawa; Hitoshi Satoh; Naoto Aoki; Yasuyuki Morishita; Norifumi Tsukamoto; Masamitsu Karasawa; Yasunobu Nonaka; Mami Shiota; Yoshihisa Nojima; Shigeo Mori
Journal:  Jpn J Cancer Res       Date:  2002-01

7.  The Frequency of Double Expresser in Selected Cases of High Grade Diffuse Large B-Cell Lymphomas.

Authors:  Maria Naseem; Muhammad Asif; Muhammad Tahir Khadim; Hafeez Ud-Din; Shahid Jamal; Iman Shoaib
Journal:  Asian Pac J Cancer Prev       Date:  2020-04-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.